Andreas Boldt - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Andreas Boldt

Showing results (51-60 of 56) with videos related to

Pageof 6

Sort By:

You have reached the last page of results.This site can display upto 56 results.

Leukemia|January 6, 2024

Cellular dynamics following CAR T cell therapy are associated with response and toxicity in relapsed/refractory myelomaLuise Fischer, Nora Grieb, Patrick Born, et al.

Hemasphere|April 6, 2026

Body composition predicts poor outcomes and reveals immunometabolic dysfunction via single-cell profiling in anti-BCMA CAR T-treated myelomaThomas C Wiemers, Michael Rade, Nora Grieb, et al.

Blood Cancer Discovery|October 23, 2024

Bispecific Antibodies as Bridging to BCMA CAR-T Cell Therapy for Relapsed/Refractory Multiple MyelomaDavid Fandrei, Sabine Seiffert, Michael Rade, et al.

Leukemia|February 17, 2026

MyCARdiac score: integrating cardiac imaging and biomarkers to predict outcomes in RRMM patients receiving cilta-celThomas C Wiemers, Nora Grieb, Maximilian Ferle, et al.

Nature Cancer|April 19, 2024

Single-cell multiomic dissection of response and resistance to chimeric antigen receptor T cells against BCMA in relapsed multiple myelomaMichael Rade, Nora Grieb, Ronald Weiss, et al.

Cancer Cell|December 5, 2025

A longitudinal single-cell atlas to predict outcome and toxicity after BCMA-directed CAR T cell therapy in multiple myelomaMichael Rade, David Fandrei, Markus Kreuz, et al.

Pageof 6

Search research articles

Showing results (51-60 of 56) with videos related to

Sort By:

Pageof 6

You have reached the last page of results.This site can display upto 56 results.

Leukemia|January 6, 2024

Cellular dynamics following CAR T cell therapy are associated with response and toxicity in relapsed/refractory myelomaLuise Fischer, Nora Grieb, Patrick Born, et al.

Hemasphere|April 6, 2026

Body composition predicts poor outcomes and reveals immunometabolic dysfunction via single-cell profiling in anti-BCMA CAR T-treated myelomaThomas C Wiemers, Michael Rade, Nora Grieb, et al.

Blood Cancer Discovery|October 23, 2024

Bispecific Antibodies as Bridging to BCMA CAR-T Cell Therapy for Relapsed/Refractory Multiple MyelomaDavid Fandrei, Sabine Seiffert, Michael Rade, et al.

Leukemia|February 17, 2026

MyCARdiac score: integrating cardiac imaging and biomarkers to predict outcomes in RRMM patients receiving cilta-celThomas C Wiemers, Nora Grieb, Maximilian Ferle, et al.

Nature Cancer|April 19, 2024

Single-cell multiomic dissection of response and resistance to chimeric antigen receptor T cells against BCMA in relapsed multiple myelomaMichael Rade, Nora Grieb, Ronald Weiss, et al.

Cancer Cell|December 5, 2025

A longitudinal single-cell atlas to predict outcome and toxicity after BCMA-directed CAR T cell therapy in multiple myelomaMichael Rade, David Fandrei, Markus Kreuz, et al.

Pageof 6